Profile of Anders Bjorklund. Interview by Beth Azar.
作者信息
Bjorklund Anders
出版信息
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13137-9. doi: 10.1073/pnas.1210582109. Epub 2012 Jul 16.
Abstract
摘要
相似文献
1
Profile of Anders Bjorklund. Interview by Beth Azar.
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13137-9. doi: 10.1073/pnas.1210582109. Epub 2012 Jul 16.
2
Bror Rexed (1914-2002).
J Neurol. 2008 Dec;255(12):1988-9. doi: 10.1007/s00415-008-0927-2. Epub 2008 Jul 7.
3
The life of Bo K. Siesjö, MD, PhD, 1930-2013.
Int J Stroke. 2014 Jan;9(1):2-4. doi: 10.1111/ijs.12237.
4
The Bernstein prize.
Motor Control. 2014 Oct;18(4):327-30. doi: 10.1123/mc.2013-0093.
5
Chemical signaling in the nervous system in health and disease: Nils-Ake Hillarp's legacy.
Prog Neurobiol. 2010 Feb 9;90(2):71-4. doi: 10.1016/j.pneurobio.2009.10.006. Epub 2009 Oct 20.
6
Profile of Shelley E. Taylor. Interview by Beth Azar.
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20153-5. doi: 10.1073/pnas.1015740107. Epub 2010 Nov 15.
7
[The Russian trace in neurosciences].
Ross Fiziol Zh Im I M Sechenova. 2009 Feb;95(2):172-4.
8
Profile of Barry Ganetzky.
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11515-7. doi: 10.1073/pnas.0701626104. Epub 2007 Jul 2.
9
RF Thompson: a bridge between 20th and 21st century neuroscience.
Neurobiol Learn Mem. 2011 Feb;95(2):103-4. doi: 10.1016/j.nlm.2010.12.006. Epub 2011 Jan 8.
10
Profile of Ivan Izquierdo.
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):14947-9. doi: 10.1073/pnas.1010117107. Epub 2010 Aug 9.
本文引用的文献
1
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9. doi: 10.1073/pnas.1200575109. Epub 2012 Feb 6.
2
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
Brain. 2007 Jul;130(Pt 7):1819-33. doi: 10.1093/brain/awm082. Epub 2007 Apr 23.
3
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Ann Neurol. 2003 Sep;54(3):403-14. doi: 10.1002/ana.10720.
4
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
N Engl J Med. 2001 Mar 8;344(10):710-9. doi: 10.1056/NEJM200103083441002.
5
Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Brain Res. 2000 Dec 15;886(1-2):82-98. doi: 10.1016/s0006-8993(00)02915-2.
6
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Nat Neurosci. 1999 Dec;2(12):1137-40. doi: 10.1038/16060.
7
Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor.
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8607-11. doi: 10.1073/pnas.91.18.8607.
8
9
10
Functional reactivation of the deafferented neostriatum by nigral transplants.
Nature. 1981 Feb 5;289(5797):497-9. doi: 10.1038/289497a0.
Zotero 插件